ly-m001
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 30, 2023 (NCT06162338)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tree pollenImmunity, desensitized
Tree pollen immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06528080 | Early Phase 1 (Phase 1) | Aug 1, 2024 | Jiao Tong University |
| NCT06818838 | Phase 1/Phase 2 (Phase 2) | Jul 5, 2024 | Chinese Academy of Medical Sciences, Lingyi Biotech Co., Ltd. |
| NCT06162338 | N/A | Oct 30, 2023 | Lingyi Biotech Co., Ltd., Zhejiang University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lingyi Biotech Co., Ltd. | For profit | 2 | 1 | 2 | 2023 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Jiao Tong University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Zhejiang University | Academic/Hospital | 1 | 1 | 1 | 2023 |
4 organizations
Page 1 / 1